人源化免疫肺癌小鼠模型的建立及其在程序性死亡受体1抑制剂疗效评估中的作用
周 箴1，徐云华1，张菲菲2，赵 艺1，郭 林2，付国龙2，沈盛萍1，冷雪娇1
Establishment of a lung cancer momodel with humanized immunity and its role in efficacy evaluation of programmed death-1 inhibitors
ZHOU Zhen, XU Yun-hua, ZHANG Fei-fei, ZHAO Yi, GUO Lin, FU Guo-long, SHEN Sheng-ping, LENG Xue-jiao
上海交通大学学报（医学版）
.
2020, (1): 37
.
DOI: 10.3969/j.issn.1674-8115.2020.01.006
